Exceptional Responders Initiative: Questions and Answers
NCI has embarked on the Exceptional Responders Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1085271.htm
- Syndication ID: 19358
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:12 PM
- Date Syndication Updated: Wednesday, August 25, 2021 at 06:16 AM
Tags
General:
response
feature
therapy
drug
DNA
Colon Cancer
molecular
gene
responders
ERI
exceptional
Embed Code Snippet
To get the embed code snippet please Login.
